Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1983]

Blinatumomab added to chemotherapy improves disease-free survival in newly...

Dr Rachel Rau - University of Washington, Seattle, USA

Blinatumomab added to chemotherapy improves disease-free survival in newly diagnosed NCI standard risk paediatric B-ALL ( Dr Rachel Rau - University of Washington, Seattle, USA )

Outcomes and survival in newly diagnosed, older, AML patients from the Beat AML...

Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA

Outcomes and survival in newly diagnosed, older, AML patients from the Beat AML master trial in the venetoclax/azacitidine age ( Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA )

IDH2 mutation associated with favourable outcome in older adults with newly...

Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA

IDH2 mutation associated with favourable outcome in older adults with newly diagnosed ALL treated with lower-intensity therapy ( Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA )

Demographics, characteristics, survival and outcomes in older, untreated, AML...

Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA

Demographics, characteristics, survival and outcomes in older, untreated, AML with NPM1 mutations or KMT2A rearrangements ( Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA )

Beat AML master trial update: A clinical trial for acute myeloid leukaemia

Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA

Beat AML master trial update: A clinical trial for acute myeloid leukaemia ( Dr Ashley Yocum - Leukemia & Lymphoma Society, New York, USA )

Impact of MRD on progression-free survival in MM patients treated with...

Dr Elias Mai - University Hospital Heidelberg, Heidelberg, Germany

Impact of MRD on progression-free survival in MM patients treated with isatuximab, lenalidomide, bortezomib and dexamethasone ( Dr Elias Mai - University Hospital Heidelberg, Heidelberg, Germany )

IRANCANSURV: Dissecting the variances in childhood cancer survival across Iran

Dr Saeed Nemati - International Agency for Research on Cancer , Lyon, France

IRANCANSURV: Dissecting the variances in childhood cancer survival across Iran ( Dr Saeed Nemati - International Agency for Research on Cancer , Lyon, France )

30 minute infusion of isatuximab shows potential in newly diagnosed multiple...

Prof Philippe Moreau - University Hospital of Nantes, Nantes, France

30 minute infusion of isatuximab shows potential in newly diagnosed multiple myeloma ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )

Understanding cognitive impairment for elderly patients undergoing CAR T therapy

Dr Ashley Rosko - The Ohio State University, Columbus, USA

Understanding cognitive impairment for elderly patients undergoing CAR T therapy ( Dr Ashley Rosko - The Ohio State University, Columbus, USA )

SIOG 2024: Updates in haematology

Dr Ashley Rosko - The Ohio State University, Columbus, USA

SIOG 2024: Updates in haematology ( Dr Ashley Rosko - The Ohio State University, Columbus, USA )

Expectations and priorities of older patients with cancer: the PRIORITY...

Dr Camille Chakiba - Institute Bergonié, Bordeaux, France

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study ( Dr Camille Chakiba - Institute Bergonié, Bordeaux, France )

Isa-VRd shows greater efficacy compared to VRd in transplant-ineligible NDMM...

Prof Meletios Dimopoulos - University of Athens, Athens, Greece

Isa-VRd shows greater efficacy compared to VRd in transplant-ineligible NDMM patients ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )

More from ecancer